DXN buys back shares for MYR 654,332.21
Bitget2026/10/09 09:48DXN Holdings bought back 1,420,300 ordinary shares on Oct. 9, 2026, holding all as treasury shares. Purchase prices ranged from MYR 0.46 to MYR 0.465 per share; total consideration was MYR 654,332.21. Outstanding treasury shares rose to 92,814,800, representing 1.86% of issued shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DXN Holdings Bhd published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3713727) on October 09, 2026, and is solely responsible for the information contained therein.
- DXN Holdings bought back 1,420,300 ordinary shares on Oct. 9, 2026, holding all as treasury shares.
- Purchase prices ranged from MYR 0.46 to MYR 0.465 per share; total consideration was MYR 654,332.21.
- Outstanding treasury shares rose to 92,814,800, representing 1.86% of issued shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
Bernstein Downgrades Nvidia Rating and Target Price

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity
Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.

The White House did not intervene in the decision-making of Nvidia's board of directors.